GreenLeaf Brings Revenue and Expertise to Endexx
Shared by: marijuanaindex.org
Endexx Enters Into Definitive Agreement to Acquire GreenLeaf Consulting LLC
CAVE CREEK, AZ–(Marketwired – Jul 2, 2014) – Endexx Corporation (OTC Pink: EDXC) (PINKSHEETS: EDXC), a provider of innovative medical marijuana management and technology solutions, announced today that it has entered into a definitive agreement to acquire the operations and services of GreenLeaf Consulting LLC., a pioneering New Jersey consulting firm for the medical marijuana industry.
GreenLeaf Consulting provides consulting and advisory services to the cannabis industry participants in several states to assist with application preparation, securing licensing and compliance protocol. Mr. Todd Davis, CEO Endexx, stated: “Mr. Stevens bring Endexx a high level of expertise in both compliance matters and political navigation in the legal Medical Cannabis industry. His background and success provide a powerful and immediate presence in the Midwest and East coast states. The Endexx management team continues to strengthen and we are very excited to work with our new partner, Joe Stevens.”
Mr. Joseph Stevens, Founder and President of Greenleaf Consulting and Greenleaf Compassion Center of New Jersey, stated: “I am excited to collaborate with the Endexx team. My proven experience guiding medical marijuana companies through complex regulatory requirements, coupled with Endexx’s outstanding technology solutions, creates a one-stop shop for seed to sale compliance solutions for the cannabis industry. I anticipate that our strategic alliance will provide Endexx and Greenleaf Consulting with new opportunities and synergies that will allow us to continue to significantly grow in our market.”
Joseph Stevens is an East Coast pioneer in the medical marijuana industry. Joseph single handedly navigated through NJ’s highly restrictive Compassionate Use of Medicinal Marijuana Act and Regulations, opening Greenleaf Compassion Center in December 2012, the first operational facility in the state. He worked hand in hand with the NJ Department of Health and Senior Services to meet the stringent State compliance requirements including, but not limited to security, inventory management, risk assessment, personnel management, cultivation procedures, and safe patient access. He assisted the Department of Health in establishing laboratory testing including the development of protocol for isolating and identifying quantities of THC, THC-A and CBD’s. The results of his success with compliance set the standard for the remaining licensees to meet in order to be approved for becoming operational.
Joseph created Greenleaf Consulting, LLC and consulted for Curaleaf in Simsbury CT to assist with their marijuana production facility application. Curaleaf was one of four producer applicants awarded permitting in January 2014. He has also provided consulting services in Massachusetts for Be Well Organics and MassMedi-Spa. He has most recently been engaged to assist an Illinois group with licensing and is in discussions with others in Arizona, New Hampshire, and Illinois who are all in pursuit of licensing.
Joseph has donated countless hours to working with parents of children with autism and seizure disorders who are interested in CBD treatment. He has also consulted with many public office officials as well as regulatory personnel in New York, Delaware, and Oregon to provide insight into the application processes, development of rules and regulations, and compliance matters as they relate to the introduction of state marijuana programs.
Under the terms of the definitive agreement, Endexx and GreenLeaf establish a long term relationship to capitalize on growth opportunities arising from the adoption of states’ medical marijuana programs. The relationship allows the integration of Greenleaf into the M3hub compliance platform and supports the implementation of standardized solutions for the industry, enhancing the overall value of the offering.
Endexx provides innovative medical marijuana management and technology solutions. The Company has two products that launched in the first half of 2014 — the m3hub and the Autospense™. Both products provide essential solutions to promote regulatory compliance and full accountability through “seed to sale” inventory management and tracking. Based on principles developed by the pharmacological industry, the m3hub database is the first standardized software platform for tracking pharmaceutical grade marijuana to support a Centralized Medical Marijuana Industry Repository and maintain compliance with the laws of the federal government and state and local regulatory bodies. The Autospense™ is a high-tech marijuana inventory control and dispensing machine, which provides up to the minute accounting details and protects the security of the product as well as the patient. By automating the dispensing process, Autospense™ increases productivity and reduces costs for marijuana retailers, while enhancing their service quality by reducing transaction time for customers.www.endexx.com, www.m3hub.com, www.autospense.com
Safe Harbor Notice
This press release may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company’s business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company’s periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.